专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明申请

WO2011146808A2 TOPICAL FORMULATION FOR A JAK INHIBITOR 审中-公开
标题翻译： JAK抑制剂的局部制剂
公开(公告)号：WO2011146808A2
公开(公告)日：2011-11-24
申请号：PCT/US2011/037291
申请日：2011-05-20
申请人： INCYTE CORPORATION , PARIKH, Bhavnish , SHAH, Bhavesh , YELESWARAM, Krishnaswamy
发明人： PARIKH, Bhavnish , SHAH, Bhavesh , YELESWARAM, Krishnaswamy
IPC分类号： A61K9/107 , A61K31/519 , A61K47/10 , A61K9/00
CPC分类号： A61K31/519 , A61K9/0014 , A61K9/107 , A61K47/06 , A61K47/10 , A61K47/14 , A61K47/24 , A61K47/26 , A61K47/36
摘要： This invention relates to pharmaceutical formulations for topical skin application comprising (R)-3-cyclopentyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]propanenitrile, or a pharmaceutically acceptable salt thereof, and use in the treatment of skin disorders.
摘要翻译：本发明涉及用于局部皮肤应用的药物制剂，其包含（R）-3-环戊基-3- [4-（7H-吡咯并[2,3-d]嘧啶-4-基）-1H-吡唑-1-基] 丙腈或其药学上可接受的盐，并用于治疗皮肤病症。

2. 发明申请

WO2009109993A1 EXTENDED RELEASE DOSAGE FORM OF PALIPERIDONE 审中-公开
标题翻译：延长释放剂量的PALIPERIDONE
公开(公告)号：WO2009109993A1
公开(公告)日：2009-09-11
申请号：PCT/IN2009/000072
申请日：2009-02-03
申请人： TORRENT PHARMACEUTICALS LTD. , MURUGESAN, Ganesan , ABRAHAM, Jaya , GUPTA, Vinodkumar , SHAH, Bhavesh
发明人： MURUGESAN, Ganesan , ABRAHAM, Jaya , GUPTA, Vinodkumar , SHAH, Bhavesh
IPC分类号： A61K9/28 , A61K31/519
CPC分类号： A61K9/2846 , A61K9/284 , A61K31/519
摘要： The present invention relates to an extended release solid oral pharmaceutical composition comprising Paliperidone or its pharmaceutically acceptable salts and process for preparing the same.
摘要翻译：本发明涉及包含哌啶酮或其药学上可接受的盐的延长释放固体口服药物组合物及其制备方法。

3. 发明申请

WO2006118895A3 WOOD PARTICLE FILLED POLYVINYL CHLORIDE COMPOSITES AND THEIR FOAMS 审中-公开
公开(公告)号：WO2006118895A3
公开(公告)日：2006-11-09
申请号：PCT/US2006/015774
申请日：2006-04-25
申请人： MICHIGAN STATE UNIVERSITY , MATUANA, Laurent, M. , HEIDEN, Patricia, A. , SHAH, Bhavesh
发明人： MATUANA, Laurent, M. , HEIDEN, Patricia, A. , SHAH, Bhavesh
IPC分类号： B29C47/00
摘要： Extruded composite compositions of PVC and wood particles containing chitosan or chitin as a coupling agent are described. The composite compositions have improved physical and mechanical properties .

4. 发明申请

WO2010026467A3 CONTROLLED RELEASE TABLET OF A HIGHLY WATER SOLUBLE ACTIVE AGENT SUCH AS LEVETIRACETAM, OR CITICOLINE 审中-公开
标题翻译：高水溶性活性物质的控制释放片如胆固醇或中性纤维素
公开(公告)号：WO2010026467A3
公开(公告)日：2011-06-03
申请号：PCT/IB2009006733
申请日：2009-09-03
申请人： TORRENT PHARMACEUTICALS LTD , ABRAHAM JAYA , GUPTA VINODKUMAR , SHAH BHAVESH
发明人： ABRAHAM JAYA , GUPTA VINODKUMAR , SHAH BHAVESH
IPC分类号： A61K9/20
CPC分类号： A61K9/2846 , A61K9/2027 , A61K9/284 , A61K31/4015
摘要： The present invention relates to a solid oral controlled release dosage form comprising high solubility active ingredient, wherein the dosage form is manufactured by single step granulation using at least one hydrophobic release controlling agent. The said dosage form is further coated using at least one hydrophobic release controlling agent. The present invention further discloses the process for preparing the said dosage form. Preferred water soluble drugs are levetiracetam or citicoline.
摘要翻译：本发明涉及包含高溶解度活性成分的固体口服控释剂型，其中所述剂型通过使用至少一种疏水释放控制剂的单步造粒制备。所述剂型使用至少一种疏水释放控制剂进一步包衣。本发明还公开了制备所述剂型的方法。优选的水溶性药物是左乙拉西坦或胞二磷胆碱。

5. 发明申请

WO2010026467A2 CONTROLLED RELEASE DOSAGE FORM OF HIGH SOLUBILITY ACTIVE INGREDIENT 审中-公开
标题翻译：高可溶性活性成分的控制释放剂量形式
公开(公告)号：WO2010026467A2
公开(公告)日：2010-03-11
申请号：PCT/IB2009/006733
申请日：2009-09-03
申请人： TORRENT PHARMACEUTICALS LTD. , ABRAHAM, Jaya , GUPTA, Vinodkumar , SHAH, Bhavesh
发明人： ABRAHAM, Jaya , GUPTA, Vinodkumar , SHAH, Bhavesh
IPC分类号： A61K31/4015
CPC分类号： A61K9/2846 , A61K9/2027 , A61K9/284 , A61K31/4015
摘要： The present invention relates to a solid oral controlled release dosage form comprising high solubility active ingredient, wherein the dosage form is manufactured by single step granulation using atleast one hydrophobic release controlling agent. The said dosage form is further coated using atleast one hydrophobic release controlling agent. The present invention further discloses the process for preparing the said dosage form.
摘要翻译：本发明涉及包含高溶解度活性成分的固体口服释药剂型，其中所述剂型通过使用至少一种疏水释放控制剂的单步造粒制造。所述剂型使用至少一种疏水释放控制剂进一步包衣。本发明还公开了制备所述剂型的方法。

6. 发明申请

WO2008062470A2 STABILIZED CONTROLLED RELEASE DOSAGE FORM OF GLICLAZIDE 审中-公开
标题翻译：稳定的控释释药剂型GLICLAZIDE
公开(公告)号：WO2008062470A2
公开(公告)日：2008-05-29
申请号：PCT/IN2007/000496
申请日：2007-10-18
申请人： TORRENT PHARMACEUTICALS LIMITED , SAMANTA, Gour , SHRIVASTAVA, Rajneesh , SHAH, Bhavesh , ABRAHAM, Jaya
发明人： SAMANTA, Gour , SHRIVASTAVA, Rajneesh , SHAH, Bhavesh , ABRAHAM, Jaya
IPC分类号： A61K9/16 , A61K9/20 , A61K31/64
CPC分类号： A61K9/2009 , A61K9/1611 , A61K9/1652 , A61K9/1694 , A61K9/2054 , A61K9/2095 , A61K31/64
摘要： The present invention is directed to stabilized controlled release dosage form of Gliclazide, exhibiting pH independent release profile over a wide range, having one or more release controlling polymer and free from saccharide component and optionally free from binder and process for preparing such dosage form.
摘要翻译：本发明涉及格列齐特的稳定的控释剂型，其在宽范围内具有pH独立的释放特征，其具有一种或多种释放控制聚合物并且不含糖组分，并且任选不含粘合剂和用于制备该剂型的方法。

7. 发明申请

WO2018005120A1 MULTIPLE SERVER ARCHITECTURE, SERVER MODULE, AND COOLER MODULE SYSTEMS AND ARCHITECTURE 审中-公开
标题翻译：多服务器体系结构，服务器模块和冷却器模块系统和体系结构
公开(公告)号：WO2018005120A1
公开(公告)日：2018-01-04
申请号：PCT/US2017/037801
申请日：2017-06-15
申请人： SHAH, Bhavesh , TANGO TECH, INC.
发明人： SHAH, Bhavesh
IPC分类号： B60H3/00
摘要： Embodiments of multiple server architecture with server modules and cooler modules wherein the server modules may be slide from the server architecture back to front to enable servers to be seated or removed transversely from a server module relative to server architecture front. Other embodiments may be described and claimed.
摘要翻译：具有服务器模块和冷却器模块的多服务器体系结构的实施例，其中服务器模块可以从服务器体系结构向后滑动到前面以使服务器能够相对于服务器体系结构从服务器模块横向安装或移除面前。其他实施例可以被描述和要求保护。

8. 发明申请

WO2013109599A1 WASTE MANAGEMENT SYSTEMS WITH ULTRAVIOLET LIGHT ACTIVATED MALODOR CONTROL COMPOUNDS 审中-公开
标题翻译：具有超紫外光激活的马尔多夫控制化合物的废物管理系统
公开(公告)号：WO2013109599A1
公开(公告)日：2013-07-25
申请号：PCT/US2013/021695
申请日：2013-01-16
申请人： NESTEC SA , HUCK, Nathan, Foster , DONAVON, Mark, A. , DIXON, Dan, Kenneth , SHAH, Bhavesh
发明人： HUCK, Nathan, Foster , DONAVON, Mark, A. , DIXON, Dan, Kenneth , SHAH, Bhavesh
IPC分类号： A01K29/00 , A01K1/01
CPC分类号： A01K1/0107
摘要： The invention provides waste management systems having ultraviolet light activated malodor control compounds and methods for activating such compounds. In a general aspect, the waste management system includes a litter box and an ultraviolet light emitting device attachable to the litter box. The litter box contains a litter having a photocatalyst that is activated by ultraviolet light, which triggers the neutralization of malodorants and the destruction of microbes that produce malodors within the litter box. The ultraviolet light emitting device can also be adaptable to receive at least one fragrance cartridge and disseminate the contents of the cartridge. The ultraviolet light emitting device can be used in conjunction with a sensor on the ultraviolet light emitting device or the litter box to determine when an animal has finished using the litter box.
摘要翻译：本发明提供了具有紫外光激活恶臭控制化合物的废物管理系统和激活这些化合物的方法。在一般方面，废物管理系统包括可以连接到垃圾箱的垃圾箱和紫外线发射装置。垃圾箱包含具有由紫外线激活的光催化剂的垃圾，其触发臭味剂的中和和在垃圾箱内产生恶臭的微生物的破坏。紫外线发射装置还可以适应于接收至少一个香料盒并散布盒的内容物。紫外线发射装置可以与紫外线发射装置或垃圾箱上的传感器结合使用，以确定动物何时完成使用垃圾箱。

9. 发明申请

WO2011146808A3 TOPICAL FORMULATION FOR A JAK INHIBITOR 审中-公开
标题翻译： JAK抑制剂的局部制剂
公开(公告)号：WO2011146808A3
公开(公告)日：2012-06-07
申请号：PCT/US2011037291
申请日：2011-05-20
申请人： INCYTE CORP , PARIKH BHAVNISH , SHAH BHAVESH , YELESWARAM KRISHNASWAMY
发明人： PARIKH BHAVNISH , SHAH BHAVESH , YELESWARAM KRISHNASWAMY
IPC分类号： A61K9/107 , A61K9/00 , A61K31/519 , A61K47/06 , A61K47/10
CPC分类号： A61K31/519 , A61K9/0014 , A61K9/107 , A61K47/06 , A61K47/10 , A61K47/14 , A61K47/24 , A61K47/26 , A61K47/36
摘要： This invention relates to pharmaceutical formulations for topical skin application comprising (R)-3-cyclopentyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]propanenitrile, or a pharmaceutically acceptable salt thereof, and use in the treatment of skin disorders.
摘要翻译：本发明涉及用于局部皮肤应用的药物制剂，其包含（R）-3-环戊基-3- [4-（7H-吡咯并[2,3-d]嘧啶-4-基）-1H-吡唑-1-基] 丙腈或其药学上可接受的盐，并用于治疗皮肤病症。

10. 发明申请

WO2011149540A1 MULTIPLE VOLATILE MATERIAL DISPENSING DEVICE AND OPERATING METHODOLOGIES THEREFORE 审中-公开
标题翻译：多种挥发性物质分配装置及其操作方法
公开(公告)号：WO2011149540A1
公开(公告)日：2011-12-01
申请号：PCT/US2011/000946
申请日：2011-05-26
申请人： S. C. JOHNSON & SON, INC. , LUC, Tai, P. , MICHAELS, Kenneth, W. , POLZIN, Megan, L. , SHAH, Bhavesh
发明人： LUC, Tai, P. , MICHAELS, Kenneth, W. , POLZIN, Megan, L. , SHAH, Bhavesh
IPC分类号： A61L9/14 , A61L9/12 , A61L9/03
CPC分类号： A61L9/14 , A61L9/035 , A61L9/125 , A61L2209/111
摘要： A dispensing device includes a controller and first and second actuators coupled to the controller and adapted to actuate first and second containers, respectively, to dispense volatile material therefrom. The device further includes a sensor coupled to the controller for detecting an environmental condition. The controller is configured to operate in a first period during which the first and second actuators are inactive, in a second period during which the first actuator is controlled to periodically actuate the first container at a first frequency to dispense volatile material therefrom, and in a third period during which the second actuator is controlled to periodically actuate the second container at a second frequency to dispense volatile material therefrom. If the sensor has detected the environmental condition, the controller is configured to control the first and/or second actuators to periodically actuate the first and/or second containers, respectively, during a fourth period at a third frequency different than the first and second frequencies to dispense volatile material therefrom.
摘要翻译：分配装置包括控制器，第一和第二致动器联接到控制器并且适于分别致动第一和第二容器以从其分配挥发性物质。该装置还包括耦合到控制器的传感器，用于检测环境状况。控制器被配置为在第一时间段内操作第一和第二致动器不起作用的第一时间段，在第二周期期间，第一致动器被控制以周期性地以第一频率致动第一容器以从其分配挥发性材料，并且在控制第二致动器以第二频率周期性地致动第二容器的第三周期以从其分配挥发性材料。如果传感器已经检测到环境条件，则控制器被配置为控制第一和/或第二致动器在第四周期期间以不同于第一和第二频率的第三频率分别周期性地致动第一和/或第二容器从中分配挥发性物质。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式